Career Opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of more than 90 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used by more than a thousand labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Due to continuous growth, we are looking for:

Which personal data do we collect of our applicants? Please see our privacy policy.
Improved Products
Multiple endocrine neoplasia (MEN) type1, 4; Pituitary adenoma predisposition syndrome
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV); Feingold syndrome
Long QT syndrome (LQT)
Ehlers-Danlos syndrome type III (EDSIII); type IV (EDSIV)
Neurofibromatosis type 2 (NF2)
Tuberous sclerosis complex (TSC)
P337-TSC2 Confirmation
Tuberous sclerosis complex (TSC)
P125-Mitochondrial DNA
Mitochondrial DNA (mtDNA)
Newsletter  |  Home  |  Privacy Policy  |  Terms and Conditions  |  Search  |  Sitemap  |  Copyright © 2019 MRC-Holland